Real-time enrollment status for this accelerated phase chronic myelogenous leukemia, bcr-abl1 positive clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:20 PM UTC
| NCT Number | NCT02727803 |
| Recruiting Status | Recruiting |
| Condition | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 13, 2026: Clinical trial NCT02727803 is currently recruiting participants. This clinical trial study for accelerated phase chronic myelogenous leukemia, bcr-abl1 positive is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02727803 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02727803 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.